The FDA's move to incorporate Bayesian statistical methods into clinical trials of drugs and biologics garnered special treatment in JAMA this week. JAMA published three perspectives -- two welcoming ...

The US FDA has issued draft guidance supporting the use of Bayesian statistical models in drug and biologic trials, enabling sponsors to integrate prior and real-world data into study designs. This ...

Industry groups and drugmakers want the US Food and Drug Administration (FDA) to explicitly clarify that Bayesian statistical methods can be used for products beyond those intended for children and ...